Found 17 articles for: "barrier"
Treatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients
June 2026 | Volume 25 | Issue 6 | Features | 572 | Copyright © June 2026
Skin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments
December 2025 | Volume 24 | Issue 12 | Original Article | 1239 | Copyright © December 2025
Background: A novel gel-matrix moisturizer was designed to 1) deliver immediate, long-lasting hydration benefits in a lightweight, non-greasy, noncomedogenic formula that is suit...
Read MoreSAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare
October 2025 | Volume 24 | Issue 10 | Original Article | 1012 | Copyright © October 2025
Background: Atopic dermatitis (AD) is a common heterogeneous disorder that typically starts in infancy and early childhood, is associated with the development of comorbidities, a...
Read MoreSkin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin
October 2025 | Volume 24 | Issue 10 | Original Article | 1029 | Copyright © October 2025
Read MoreStudy of Adjuvant Sensitive-Skin Cleansing and Moisturizing Regimen in Plaque Psoriasis
August 2025 | Volume 24 | Issue 8 | Original Article | 739 | Copyright © August 2025
Read MoreNovel 2% Salicylic Acid Cleanser With Polymeric Cleansing Technology Treats Acne Without Compromising Skin Barrier
June 2025 | Volume 24 | Issue 6 | Original Article | 570 | Copyright © June 2025
Background: A novel acne cleanser containing 2% Salicylic acid (SA), Polymeric Cleansing Technology (PCT), and a microgel complex, was evaluated for its efficacy in treating mild...
Read MoreImprovement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%
April 2025 | Volume 24 | Issue 4 | Original Article | 397 | Copyright © April 2025
Background: Topical medications commonly prescribed for the treatment of acne vulgaris may be limited by application-site dryness, which can result in skin barrier damage. This s...
Read MoreEffects of a Moisturizer Containing Colloidal Oatmeal and Filaggrin Technology on Staphylococcus Species In Vitro
April 2025 | Volume 24 | Issue 4 | Features | 416 | Copyright © April 2025
The pathophysiology of atopic dermatitis (AD) is multifactorial, with genetic predisposition, environmental exposures, and dysbiosis of the skin microbiome all associated with disease activi...
Read MoreEffects on the Skin Microbiome by a Moisturizer Formulated for Eczema-Prone and Sensitive Skin
March 2025 | Volume 24 | Issue 3 | Original Article | 275 | Copyright © March 2025
Background: Cutaneous dysbiosis contributes to the pathophysiology of atopic dermatitis and potentially that of sensitive skin; regulation of the bacterial communities through sk...
Read MoreKeeping Cool: An Updated Review on Cold-Induced Dermatoses and Cold-Associated Injury
March 2025 | Volume 24 | Issue 3 | Features | 333 | Copyright © March 2025
Efficacy and Consumer Perception of Topical Over-the-Counter Regimens Involving Beta-Hydroxy Acid for Acne Vulgaris
February 2025 | Volume 24 | Issue 2 | Original Article | 162 | Copyright © February 2025
The use of alpha-hydroxy acids (AHAs) and beta-hydroxy acids (BHAs) for acne treatment and their integration into daily skincare routines for better cosmetic outcomes has increasingly become a no...
Read MorePromoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis
January 2024 | Volume 23 | Issue 1 | Original Article | 1253 | Copyright © January 2024
Introduction: Most people are living into their sixties and beyond. Fundamental changes in chronologically aged skin have significant and widespread dermatological implications. ...
Read MorePsoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 773 | Copyright © August 2023
Background: Psoriasis is a chronic immune-mediated dermatologic disorder with multisystemic comorbidities, which is effectively treated with a range of prescription therapies. St...
Read MoreRacial and Ethnic Variations in Skin Barrier Properties and Cultural Practices in Skin of Color Newborns, Infants, and Children
July 2023 | Volume 22 | Issue 7 | Original Article | 657 | Copyright © July 2023
Background: The skin of newborns and infants of all races/ethnicity is more susceptible to skin barrier disruption than adult skin. This consensus paper offers insights into pote...
Read MoreEvolving Concepts in Psoriasis: Special Considerations for Patients With Skin of Color, Skin Barrier Dysfunction, and the Role of Adjunctive Skin Care
October 2022 | Volume 21 | Issue 10 | Original Article | 1054 | Copyright © October 2022
Background: Despite considerable advances in our understanding of the pathogenesis and treatment of psoriasis, data pertaining to racial/ethnic variations, effects on barrier function...
Read MoreARTICLE: Evolution of Skin Barrier Science for Healthy and Compromised Skin
April 2021 | Volume 20 | Issue 4 | Supplement Individual Articles | s3 | Copyright © April 2021
Skin is a complex organ comprised of multiple cell types and microstructures that work in concert to serve critical functions and support the body’s homeostasis. It is the outermost, cornified l...
Read MoreARTICLE: Recent Advances in Skin Barrier Research: From Basic Science to Clinical Discovery
April 2021 | Volume 20 | Issue 4 | Supplement Individual Articles | s2 | Copyright © April 2021
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
